AGMB · Agomab Therapeutics NV
Market Cap
$648.60M
Shares
49.25M
Agomab Therapeutics NV Earnings Call Transcripts
Quarterly earnings calls for Agomab Therapeutics NV (AGMB), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
No Earnings Calls Available
No earnings call events are available for this stock yet.
Key facts
CIK
2020932
CUSIP
00860C102
13F (30d)
29 filings
29 filers
Visit website
Investor relations